Answers are grounded in this paper and cite their sources.
Objective To compare acute-phase clinical characteristics between children with and without subsequent post-infectious bronchiolitis obliterans (PIBO) or bronchitis obliterans, and to describe the available evidence on glucocorticoid use and treatment timing. These diagnoses were considered related post-infectious obstructive airway outcomes, not interchangeable conditions. Methods PubMed, Embase, Web of Science, and Cochrane Library were searched from inception to June 9, 2026. Eligible observational studies involved children or adolescents with adenovirus or Mycoplasma pneumoniae respiratory infection, compared those with and without subsequent BO/PIBO, and provided extractable group-specific data; adult-only studies, non-comparative reports, non-infectious BO, and reports without usable comparative data were excluded. Diagnostic definitions were retained as reported, with sensitivity analyses excluding the bronchoscopically defined bronchitis obliterans study. Coinfection denoted an additional respiratory pathogen identified during the index illness, according to the original study definitions. Two investigators independently screened studies, extracted data, and assessed quality using the Newcastle-Ottawa Scale. Review Manager 5.4 was used to pool odds ratios (ORs) or mean differences (MDs) with 95% confidence intervals (CIs). Results Six observational studies, including three retrospective cohort studies and three retrospective case-control studies, involved 2063 children (315 BO/PIBO and 1748 non-BO/non-PIBO). Reported ventilatory support was more frequent in the BO/PIBO group (OR=6.57, 95% CI: 1.85–23.40), which also had longer fever duration (MD = 2.82 days, 95% CI: 1.74–3.90) and higher white blood cell count (WBC) (MD = 1.34 × 10 9 /L, 95% CI: 0.82–1.86). Lactate dehydrogenase (LDH) was higher in the primary analysis (MD = 111.58 U/L, 95% CI: 13.71–209.44), although this difference was not consistently significant in sensitivity analyses. Alanine aminotransferase (ALT) showed no significant group difference (MD = 7.12 U/L, 95% CI: −0.49–14.72), whereas coinfection was more frequent in the BO/PIBO group (OR=3.16, 95% CI: 2.17–4.58). Excluding the bronchitis obliterans study retained the WBC and coinfection associations, whereas the LDH difference was no longer significant. Asthma and wheezing were described separately. Conclusion Several acute-phase characteristics differed between children with and without the study-defined post-infectious obliterative airway outcomes. Diagnostic differences, heterogeneous measurement schedules, and observational designs limit PIBO-specific and causal interpretation. The available evidence does not establish whether glucocorticoid use or treatment timing modifies the risk of subsequent BO/PIBO.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: